Registry HBOT in DFU

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Nov 15, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Registry HBOT in DFU," is studying the effects of Hyperbaric Oxygen Therapy (HBOT) on patients with diabetic foot ulcers (DFU). Diabetic foot ulcers are sores or wounds that can develop in people with diabetes, and they can be hard to heal. The trial aims to gather and analyze data to understand how beneficial HBOT might be for these patients, helping to improve their healing process.

To participate in this study, individuals must have diabetes and a specific type of foot ulcer that has been present for more than four weeks. They should also be willing to complete a one-year follow-up. However, certain conditions may exclude someone from joining, such as having severe lung disease, recent cancer treatment, or other serious health issues. Participants can expect regular check-ups and monitoring during the trial, which will help researchers learn more about the effectiveness of HBOT for improving healing in diabetic foot ulcers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diabetes mellitus
• • Meggitt-Wagner classification grade 2-4, existing \> 4 weeks
• • Complete 1 year follow-up
• Exclusion Criteria:
• • Chronic Obstructive Pulmonary Disease (COPD) GOLD IV
• • Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months
• • Metastasized malignancy
• • Left ventricular ejection fraction (EF) \<20% or external pacemaker
• • Recent thoracic or middle ear surgery
• • Severe epilepsy
• • Uncontrollable high fever
• • Pregnancy